On February 1, 2024, the company announced an increase in its equity buyback plan. The company increased its authority by CNY 100 million, thereby bringing the total authorization to CNY 300 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.96 CNY | -0.99% | -5.08% | -33.28% |
May. 10 | ChenGuang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
Apr. 24 | ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.28% | 634M | |
-2.00% | 277B | |
-5.38% | 91.92B | |
-4.35% | 42.95B | |
+0.75% | 41.25B | |
+6.11% | 40.01B | |
+5.54% | 38.81B | |
-13.54% | 30.87B | |
-11.43% | 27.21B | |
+7.73% | 24.19B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback.